Neutralizing Antibody
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults (NCT02599896) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-11-16 |
| Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults (NCT01993706) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-19 |
| VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected... (NCT01950325) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-08-22 |
Track Neutralizing Antibody automatically
Every clearance here is in the API, with alerts when new ones post.